Sign up to save your podcasts
Or
Share What Reclassifying Marijuana Could Mean For Research And Drug Policy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What Reclassifying Marijuana Could Mean For Research And Drug Policy
For the last 50 years, the government has classified Marijuana as a schedule one drug.
Last Tuesday, Attorney General Merrick Garland did initiate the process to reclassify marijuana as a schedule three drug. Those substances are considered by the Drug Enforcement Agency to have moderate to low potential for physical and psychological dependence.
This recommendation does not make marijuana legal at the federal level. But for the first time, the government is acknowledging marijuana's potential medical benefits.
We discuss what this move means for marijuana research, and drug policy more broadly.
Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
Last Tuesday, Attorney General Merrick Garland did initiate the process to reclassify marijuana as a schedule three drug. Those substances are considered by the Drug Enforcement Agency to have moderate to low potential for physical and psychological dependence.
This recommendation does not make marijuana legal at the federal level. But for the first time, the government is acknowledging marijuana's potential medical benefits.
We discuss what this move means for marijuana research, and drug policy more broadly.
Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
View all episodes
By NPR
4.3
44424,442 ratings
For the last 50 years, the government has classified Marijuana as a schedule one drug.
Last Tuesday, Attorney General Merrick Garland did initiate the process to reclassify marijuana as a schedule three drug. Those substances are considered by the Drug Enforcement Agency to have moderate to low potential for physical and psychological dependence.
This recommendation does not make marijuana legal at the federal level. But for the first time, the government is acknowledging marijuana's potential medical benefits.
We discuss what this move means for marijuana research, and drug policy more broadly.
Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
Last Tuesday, Attorney General Merrick Garland did initiate the process to reclassify marijuana as a schedule three drug. Those substances are considered by the Drug Enforcement Agency to have moderate to low potential for physical and psychological dependence.
This recommendation does not make marijuana legal at the federal level. But for the first time, the government is acknowledging marijuana's potential medical benefits.
We discuss what this move means for marijuana research, and drug policy more broadly.
Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
More shows like 1A
View all
Fresh Air
38,518 Listeners
The New Yorker Radio Hour
6,782 Listeners
Wait Wait... Don't Tell Me!
38,807 Listeners
The NPR Politics Podcast
25,785 Listeners
On the Media
9,193 Listeners
On Point with Meghna Chakrabarti
3,981 Listeners
Here & Now Anytime
1,001 Listeners
Code Switch
14,623 Listeners
The Daily
112,031 Listeners
Up First from NPR
56,537 Listeners
It's Been a Minute
9,065 Listeners
Throughline
16,364 Listeners
Consider This from NPR
6,396 Listeners
The Ezra Klein Show
15,852 Listeners
Sources & Methods
790 Listeners